Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chonglian oral liquid
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Anhui University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Chonglian oral liquid is a Traditional Chinese Medicine (TCM) hospital-made preparation developed by The First Affiliated Hospital of Anhui University of Chinese Medicine. It is specifically formulated for the treatment of influenza and associated fever, particularly targeting the "wind-heat attacking the lung" syndrome. The preparation is a complex mixture of herbal extracts, with its name derived from its two primary components: *Paris polyphylla* (Chonglou) and *Forsythia suspensa* (Lianqiao). These ingredients are traditionally utilized in TCM for their heat-clearing, detoxifying, and anti-inflammatory properties. The drug has been evaluated in clinical trials to assess its efficacy in reducing fever duration and alleviating respiratory symptoms in patients with influenza.
- Other names
- 重连口服液Chonglian Koufuye
Beyond the preview
Go deeper on Chonglian oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chonglian oral liquid.